Thirteen-month-old rd12 mice, when retinal degeneration had already started (Hasegawa et al., 2016a), were assigned to two groups, the BCAA-treated and non-treated control groups (N = 17 mice for each). This evidence concerns the gene RPE65 and retinal degeneration.